MedPath

Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung

Completed
Conditions
Asthma
Chronic Obstructive Pulmonary Disease
Interstitial Lung Diseases
Occupational Lung Diseases
Registration Number
NCT00511290
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Brief Summary

In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis.

The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Ages 7-80
Exclusion Criteria
  • FEV1 < 75% predicted pO2 < 75

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tel-Aviv Sourasky Medical Center

🇮🇱

Tel-Aviv, Israel

© Copyright 2025. All Rights Reserved by MedPath